PCM
BRLI

Penn Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Penn Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-52,877
Closed -$1.52M – 344
2013
Q2 		$1.52M Buy
+52,877
New +$1.46M 0.06% 269

Other funds holding BRLI

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CM
CS McKee Pittsburgh, Pennsylvania $1.09B AUM 31.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Penn Capital Management's BRLI Position: Q3 2013 in Review

Penn Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2013, closing a stake of 52,877 shares — an estimated $1.52M sold.

Penn Capital Management first reported a position in BRLI in Q2 2013 and held it in 1 quarter. The position peaked at $1.52M in Q2 2013. 175 funds tracked by Wall St. Rank hold BRLI as of Q3 2013.

  • Penn Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2013 after selling out during the quarter.
  • Penn Capital Management sold 52,877 BIO-REFERENCE LABS INC-NEW- shares in Q3 2013, an estimated $1.52M.
  • Penn Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 1 quarter.
  • Penn Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $1.52M in Q2 2013.
  • 175 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2013.

Based on Penn Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.